Skip to content
value.today

Inceptor Bio, LLC

🇺🇸 Raleigh, North Carolina, USABiotechnologyFounded 2020
Total raised
$44 M
3 rounds on record
Latest round
$3 M
Jan 2025
First round on record
Apr 2020
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Inceptor Bio, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2025$3 MNo. 3$2 to $10 million

Inceptor Bio, LLC: Raise no. 3, Jan 2025

Investors in this round

10 investors had bought by the notice of Jan 31, 2025: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in North Carolina

People named in the notice

  • Abraham S. Maingi · Executive Officer
  • Jason S. Lawrence · Executive Officer
  • Matthias S. Schroff · Executive Officer, Director
  • Derek S. Hennecke · Director
  • Elizabeth S. Smith · Director
  • George S. Fotiades · Director
  • Mark S. Gilbert · Director
  • Shailesh S. Maingi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jason Lawrence, VP Finance. Source: SEC Form D, newest notice filed Jan 31, 2025. Read the notice at the SEC.

equity, optionsSEC
Feb 2022$38 MNo. 2$10 to $50 million

Inceptor Bio, LLC: Raise no. 2, Feb 2022

Investors in this round

9 investors had bought by the notice of Mar 4, 2022: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $61 M offered; $23 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in North Carolina

People named in the notice

  • Abraham Surinder Maingi · Executive Officer, Director
  • Jason Michael Lawrence · Executive Officer
  • Matthew John Haines · Executive Officer
  • Michael Michael Nicholson · Executive Officer
  • Shailesh Surinder Maingi · Executive Officer, Director, Promoter
  • David Michael Johnston · Director
  • Derek Michael Hennecke · Director
  • Mark Michael Bamforth · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jason Lawrence, Senior Director, Finance. Source: SEC Form D, newest notice filed Mar 4, 2022. Read the notice at the SEC.

equitySEC
Apr 2020$3 MNo. 1$2 to $10 million

Inceptor Bio, LLC: Raise no. 1, Apr 2020

Investors in this round

6 investors had bought by the notice of Sep 28, 2020: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in North Carolina

People named in the notice

  • Abraham Surinder Maingi · Executive Officer, Director · Manager
  • Shailesh Surinder Maingi · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joshua D. Bryant, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed Sep 28, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Inceptor Bio, LLC chose not to state its revenue in its newest notice of a funding round (Jan 2025).

    SEC Form D · Jan 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2025

That is all the official record says: Inceptor Bio, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Inceptor Bio, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Inceptor Bio, LLC
NameRoleNamed in
Abraham S. MaingiExecutive officerJan 2025
Jason S. LawrenceExecutive officerJan 2025
Matthias S. SchroffExecutive officerJan 2025
Abraham Surinder MaingiExecutive officerMar 2022
Jason Michael LawrenceExecutive officerMar 2022
Matthew John HainesExecutive officerMar 2022
Michael Michael NicholsonExecutive officerMar 2022
Shailesh Surinder MaingiExecutive officerMar 2022
Derek S. HenneckeDirectorJan 2025
Elizabeth S. SmithDirectorJan 2025
George S. FotiadesDirectorJan 2025
Mark S. GilbertDirectorJan 2025
Matthias S. SchroffDirectorJan 2025
Shailesh S. MaingiDirectorJan 2025
Abraham Surinder MaingiDirectorMar 2022
David Michael JohnstonDirectorMar 2022
Derek Michael HenneckeDirectorMar 2022
Mark Michael BamforthDirectorMar 2022
Shailesh Surinder MaingiDirectorMar 2022
Shailesh Surinder MaingiPromoterMar 2022